In last trading session, Immunome Inc (NASDAQ:IMNM) saw 0.73 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price level of $15.75 trading at $0.78 or 5.21% at ring of the bell on the day assigns it a market valuation of $940.12M. That closing price of IMNM’s stock is at a discount of -96.57% from its 52-week high price of $30.96 and is indicating a premium of 71.43% from its 52-week low price of $4.50. Taking a look at company’s average trading volume volume of 835.40K if we extend that period to 3-months.
Immunome Inc (NASDAQ:IMNM) trade information
Upright in the green during last session for gaining 5.21%, in the last five days IMNM remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $15.75 price level, adding 1.87% to its value on the day. Immunome Inc’s shares saw a change of 47.20% in year-to-date performance and have moved 14.71% in past 5-day. Immunome Inc (NASDAQ:IMNM) showed a performance of -22.26% in past 30-days.
Immunome Inc (IMNM) estimates and forecasts
Statistics highlight that Immunome Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 83.78% of value to its shares in past 6 months, showing an annual growth rate of -45.80% while that of industry is 12.80. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -31.50% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 2.8M for the same. And 5 analysts are in estimates of company making revenue of 2.6M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -48.48% during past 5 years.
IMNM Dividends
Immunome Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
